A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft Occlusion

Clinical trial NCT00418483 · COMPLETED

Trial details

NCT number: NCT00418483
Sponsor: Grifols Therapeutics LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Arterial Occlusive Diseases

Start date: 2007-03-01
Primary completion: 2010-04-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.